US2012208774A1PendingUtilityA1

Method for inhibiting "melanoma inhibitory activity" mia

36
Assignee: BOSSERHOFF ANJA-KATRINPriority: Jan 29, 2002Filed: Feb 27, 2012Published: Aug 16, 2012
Est. expiryJan 29, 2022(expired)· nominal 20-yr term from priority
Inventors:Anja-Katrin BosserhoffReinhard BuettnerMara SzyrachGuenter AuerbachPiotr JachimczakKarl-Hermann Schlingensiepen
A61P 43/00A61P 9/14A61P 35/00A61P 35/02A61P 7/00A61P 35/04A61P 37/00A61P 31/18A61P 19/00A61K 38/00A61P 19/02C07K 7/08C07K 16/2842C07K 7/06C07K 16/3053
36
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention is directed to peptides, antibodies and antibody fragments inhibiting activity of “Melanoma Inhibitory Activity” (MIA).

Claims

exact text as granted — not AI-modified
1 - 16 . (canceled) 
     
     
         17 . An isolated peptide consisting of the amino acid SEQ ID NO: 46 modified by of glycosylation, acetylation, hydroxylation, carboxylation, phosphorylation, alkylation, myristoylation, palmitoylation, or prenylation, wherein the peptide specifically binds a MIA polypeptide comprising the amino acid sequence of SEQ ID NO: 58. 
     
     
         18 . An isolated peptide consisting of the amino acid sequence of SEQ ID NO: 46 having a modified natural amino acid, wherein the natural amino acid is modified by a substitution of one or more atoms with a functional group comprising 1 to 12 atoms selected from C, H, N, S, O, P, F, Cl, Br, I, and Se, and wherein the peptide specifically binds a MIA polypeptide comprising the amino acid sequence of SEQ ID NO: 58. 
     
     
         19 . An isolated peptide consisting of the amino acid sequence of SEQ ID NO: 46 but for the substitution of one amino acid by a natural or non-natural amino acid, wherein the peptide specifically binds a MIA polypeptide comprising the amino acid sequence of SEQ ID NO: 58. 
     
     
         20 . An isolated peptide of  claim 19 , wherein the substitution is by a non-natural amino acid selected from the group consisting of trans-3-methylproline, 2,4-methanoproline, cis-4-hydroxyproline, trans-4-hydroxyproline, N-methylglycine, allothreonine, methylthreonine, hydroxyethylcysteine, hydroxyethylhomocysteine, nitroglutamine, homoglutamine, pipecolic acid, tert-leucine, norvaline, 2-azaphenylalanine, 3-azaphenylalanine, 4-azaphenylalanine, and 4-fluorophenylalanine. 
     
     
         21 . An isolated peptide consisting of the amino acid sequence of SEQ ID NO: 46 but for the addition of one amino acid at either end, wherein the peptide specifically binds a MIA polypeptide comprising the amino acid sequence of SEQ ID NO: 58. 
     
     
         22 . An isolated peptide consisting of the amino acid sequence of SEQ ID NO: 46 but for the deletion of one amino acid, wherein the peptide specifically binds a MIA polypeptide comprising the amino acid sequence of SEQ ID NO: 58. 
     
     
         23 . A composition comprising the peptide according to  claim 17  in combination with an acceptable biodegradable polymer. 
     
     
         24 . A composition comprising the peptide according to  claim 18  in combination with an acceptable biodegradable polymer. 
     
     
         25 . A composition comprising the peptide according to  claim 19  in combination with an acceptable biodegradable polymer. 
     
     
         26 . A composition comprising the peptide according to  claim 20  in combination with an acceptable biodegradable polymer. 
     
     
         27 . A composition comprising the peptide according to  claim 21  in combination with an acceptable biodegradable polymer. 
     
     
         28 . A composition comprising the peptide according to  claim 22  in combination with an acceptable biodegradable polymer.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.